Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
12.7M
-
Number of holders
-
113
-
Total 13F shares, excl. options
-
6.1M
-
Shares change
-
-60.8K
-
Total reported value, excl. options
-
$271M
-
Value change
-
-$3.59M
-
Number of buys
-
62
-
Number of sells
-
-46
-
Price
-
$44.37
Significant Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2023
127 filings reported holding IRMD - IRADIMED CORP - Common Stock as of Q3 2023.
IRADIMED CORP - Common Stock (IRMD) has 113 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.1M shares
of 12.7M outstanding shares and own 47.92% of the company stock.
Largest 10 shareholders include Nine Ten Capital Management LLC (771K shares), Soleus Capital Management, L.P. (628K shares), BlackRock Inc. (614K shares), RENAISSANCE TECHNOLOGIES LLC (575K shares), VANGUARD GROUP INC (412K shares), RK Capital Management, LLC (301K shares), Bares Capital Management, Inc. (277K shares), Ranger Investment Management, L.P. (212K shares), DIMENSIONAL FUND ADVISORS LP (209K shares), and Russell Investments Group, Ltd. (207K shares).
This table shows the top 113 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.